Zentalis Pharmaceuticals, Inc. (ZNTL)
3.80
-0.08
(-2.06%)
USD |
NASDAQ |
Aug 28, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 98.82% |
| September 30, 2024 |
| Date | Value |
|---|---|
| June 30, 2024 | |
| March 31, 2024 | 99.20% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 61.83% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.21% |
| Return on Assets | -48.58% |
| Return on Invested Capital | -55.04% |
| Return on Net Operating Assets | -411.0% |